The global at-home testing market size accounted for USD 7,435 million in 2024 and is expected to exceed around USD 11,996 million by 2034, growing at a CAGR of 4.9% from 2024 to 2034.
The at-home testing market typically involves kits, which you can buy online or at your local pharmacy or supermarket. These kits enable you to collect biological samples, such as saliva or urine, and figure out the results for certain diseases and conditions in the privacy of your home without the guidance of a medical expert. The simple availability of self-testing kits at online stores and pharmacies without any prescription boosts market growth. The rise of the elderly population and the incidence of chronic diseases are liable for market inflation. Players in the industry are heavily investing in research and development through funding and other programs to improve the accuracy and operability of self-testing devices. Additionally, new technologies such as smartphone-integrated diagnostic kits, AI-powered analysis tools, and wearable biosensors have broadened the market.
The increase in the at-home testing market is expected to be driven by a surge in the demand for HIV testing kits, diabetes kits, etc. Furthermore, it has been beneficial for both hospitals and patients, as well as for the manufacturers. The aforementioned are expected to create lucrative opportunities for the market to grow in the future.
Published by Ajit Bansod
